Patients in need of coronary artery bypass grafting.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Omitting anti-coagulation drugs at least one week prior to surgery Patient should be a candidate for coronary artery bypass grafting Informed consent to participate in the study CPB duration less than 100 minutes
Exclusion criteria
Exclusion criteria: Allergy and the risk of anaphylaxia shock Coagulation abnormality Bleeding and hemostasis dysfunctions due to non-medical causes Patients dependent on dialysis and patients suffering from blood dyscrasia and known platelet dysfunction Pregnancy Heparin re-administration Need for emergency surgery Patients with BMIs higher than 30 Under 28 degrees hypothermia Dissent to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent of participants with number of Activated Clotting Time near normal domain (70-120) second. Timepoint: 5 minutes after the end of protamine injection. Method of measurement: Activated Clotting Time assessment with Coagulometer device according to second.;Percent of abnormal bleeding. Timepoint: Drainage assessment of the drains and chest tubes 12 hours and 36 hours after the end of surgery. Method of measurement: Drainage assessment of the drains and chest tubes according to cubic centimeter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences